Latest Headlines

Latest Headlines

Bayer's startup accelerator funds 5 device, healthcare app companies

Fresh off the sales of its interventional device unit to Boston Scientific, Bayer Healthcare is showing renewed interest in med tech via its startup accelerator.

Ex-Shire exec starts at Cortendo, Innate gets orphan nod, Ablynx trims in preclinical

In this week's EuroBiotech Report, with AstraZeneca now back in play--if it chooses--talk of M&A involving European drugmakers has ratcheted up once again after a brief, post-Shire lull. And more.

Medtronic expands hospital services push with $350M acquisition

Medtronic  wants to be known for manufacturing high-quality devices and providing related services as well. To that end, the company today announced the acquisition of privately held Italian company NGC Medical S.p.A.

Recipharm buys into Italy with $165M CMO deal

Swedish contract developer Recipharm is looking to expand its share of the European manufacturing market, trading $164.5 million for Italy's Corvette Pharmaceutical Services.

AZ may be too expensive for Pfizer, Orexo to up reliance on partners, Santhera raises cash

In this week's EuroBiotech Report, data on the antibiotic AstraZeneca is developing with Actavis' Forest Laboratories and some oncology compounds have burnished AstraZeneca's pipeline, a development that means the Anglo-Swedish drugmaker may now be too expensive to be attractive to Pfizer. And more.

NeuroSearch convicted of stock manipulation, VBL IPO unravels, Prosensa plans EMA filing

In this week's EuroBiotech Report, a court convicted NeuroSearch of stock price manipulation and imposed a fine of DKK 5 million ($0.9 million) more than four years after NeuroSearch published the clinical trial results--and subsequent reappraisal--that caused its stock to surge and slump. And more.

Smaller med techs suffer under excise tax burden

Although the biggest med tech companies likely pay the bulk of the reported $1.4 billion in excise taxes levied on the industry during its first year in 2013, the tax adds to an already heavy burden for small and midsized companies.

Baxter to add recombinant protein processing suite at Singapore plant

In the 11 years since the Singapore government created a biologics CMO to kickstart the local sector, a who's who of biopharma manufacturers have opened plants in the country. Baxter is among the latest to set up shop in Singapore and is already pushing ahead with expansion plans.

Roche commits to Danish RNA lab, £3B London incubator hits go, Biotechs in post-IPO slump

In this week's EuroBiotech Report, Roche took another step back into RNA, striking a $450 million (€335 million) deal to acquire Santaris Pharma and committing to making the Danish biotech's lab its RNA therapeutics research unit. And more.

Almirall seeks dermatology deals, Euro biotech IPOs fall short, Cellectis increases CAR-T focus

In this week's EuroBiotech Report, the last week of July was a massive one for European biotech IPOs, with BioBlast Pharma, Innocoll, Macrocure, Mapi Pharma and VBL Therapeutics all heading to the Nasdaq. All of the companies struggled though. And more.